Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ADCY9 Antikörper

ADCY9 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1944823
  • Target Alle ADCY9 Antikörper anzeigen
    ADCY9 (Adenylate Cyclase 9 (ADCY9))
    Reaktivität
    • 32
    • 28
    • 18
    Human
    Wirt
    • 47
    • 1
    Kaninchen
    Klonalität
    • 46
    • 1
    Polyklonal
    Konjugat
    • 16
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ADCY9 Antikörper ist unkonjugiert
    Applikation
    • 41
    • 19
    • 13
    • 13
    • 10
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Isotyp
    IgG1
  • Applikationshinweise
    WB: 1:1000. IHC: 1:50-1:100
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Lagerung
    4 °C,-20 °C
  • Tantisira, Small, Litonjua, Weiss, Liggett: "Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways." in: Human molecular genetics, Vol. 14, Issue 12, pp. 1671-7, (2005) (PubMed).

    Small, Brown, Theiss, Seman, Weiss, Liggett: "An Ile to Met polymorphism in the catalytic domain of adenylyl cyclase type 9 confers reduced beta2-adrenergic receptor stimulation." in: Pharmacogenetics, Vol. 13, Issue 9, pp. 535-41, (2003) (PubMed).

    Hacker, Tomlinson, Wayman, Sultana, Chan, Villacres, Disteche, Storm: "Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9)." in: Genomics, Vol. 50, Issue 1, pp. 97-104, (1999) (PubMed).

  • Target
    ADCY9 (Adenylate Cyclase 9 (ADCY9))
    Andere Bezeichnung
    ADCY9 (ADCY9 Produkte)
    Synonyme
    AC9 antikoerper, ACtp10 antikoerper, AW125421 antikoerper, D16Wsu65e antikoerper, mKIAA0520 antikoerper, xlAC antikoerper, ADCY9 antikoerper, adenylate cyclase 9 antikoerper, adenylate cyclase 9 L homeolog antikoerper, ADCY9 antikoerper, Adcy9 antikoerper, adcy9.L antikoerper, adcy9 antikoerper
    Hintergrund
    May play a fundamental role in situations where fine interplay between intracellular calcium and cAMP determines the cellular function. May be a physiologically relevant docking site for calcineurin (By similarity).
    Molekulargewicht
    150701 Da
    Gen-ID
    115
    UniProt
    O60503
    Pathways
    EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
Sie sind hier:
Kundenservice